BXPHF (Botanix Pharmaceuticals) General and Admin. Expense: $20.14 Mil (TTM As of Dec. 2025)


What is Botanix Pharmaceuticals General and Admin. Expense?

Botanix Pharmaceuticals BXPHF General and Admin. Expense is $20.14 Mil as of Dec. 2025. The stock has 7 warning signs investors should review.

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Botanix Pharmaceuticals's General and Admin. Expense for the six months ended in Dec. 2025 was $10.99 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Dec. 2025 was $20.14 Mil.

Botanix Pharmaceuticals General and Admin. Expense Related Terms

Botanix Pharmaceuticals General and Admin. Expense Historical Data

* Premium members only.

The historical data trend for Botanix Pharmaceuticals's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Botanix Pharmaceuticals General and Admin. Expense Chart

Botanix Pharmaceuticals Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
General and Admin. Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.72 2.50 2.04 4.41 21.50

Botanix Pharmaceuticals Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
General and Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.85 2.58 12.02 9.15 10.99

Botanix Pharmaceuticals General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $20.14 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a General and Admin. Expense of $20.14 Mil mean?
Botanix Pharmaceuticals (BXPHF) has a General and Admin. Expense of $20.14 Mil as of Dec. 2025. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Botanix Pharmaceuticals and its competitors.
Is Botanix Pharmaceuticals' General and Admin. Expense too high?
Botanix Pharmaceuticals' current General and Admin. Expense is $20.14 Mil.
How does Botanix Pharmaceuticals' General and Admin. Expense compare to VRTX and REGN?
Botanix Pharmaceuticals' General and Admin. Expense of $20.14 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good General and Admin. Expense for a Biotechnology company?
A good General and Admin. Expense depends on the Biotechnology industry context. However, General and Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high General and Admin. Expense mean?
A high General and Admin. Expense can signal that a stock is expensive relative to its fundamentals. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Botanix Pharmaceuticals and its competitors. Botanix Pharmaceuticals's current General and Admin. Expense is $20.14 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Botanix Pharmaceuticals stock overvalued right now?
Botanix Pharmaceuticals (BXPHF) has a current General and Admin. Expense of $20.14 Mil. The current General and Admin. Expense is $20.14 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is General and Admin. Expense calculated?
General and Admin. Expense is calculated from a company's financial statements. For Botanix Pharmaceuticals (BXPHF), the current General and Admin. Expense is $20.14 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Botanix Pharmaceuticals Business Description

Other Exchanges BOT:Australia
Address 41 - 47 Colin Street, Suite 3, West Perth, WA, AUS, 6005
Botanix Pharmaceuticals Ltd is a dermatology company. The company focuses on developing safe and effective topical treatments for serious skin conditions. It has an exclusive license to use a proprietary drug delivery system for all skin diseases. The company's product pipeline includes BTX 1503 - Moderate to Severe Acne, BTX 1204 - Atopic Dermatitis, BTX 1702 - Rosacea, Sofdra - Axillary Hyperhidrosis, and others. The majority of Revenue is derived from Australia.